首页> 外国专利> LACTOBACILLUS EXPECTABLE TO HAVE IMMUNOMODULATING ACTION AND EXTRACELLULAR POLYSACCHARIDE

LACTOBACILLUS EXPECTABLE TO HAVE IMMUNOMODULATING ACTION AND EXTRACELLULAR POLYSACCHARIDE

机译:乳酸杆菌有望具有免疫调节作用和胞外多糖

摘要

PPROBLEM TO BE SOLVED: To provide a lactobacillus strain expectable to have immunomodulating action by oral administration to human and animal, and to provide an extracellular polysaccharide. PSOLUTION: A new Lactobacillus fermentum TDS030603 strain is provided which produces a polysaccharide composed of a major component containing a tetrasaccharide comprising a 3-substituted glucose, a 6-substituted galactose, a 2,3-substituted glucose and nonreducing terminal glucose as a repeating unit and a minor component containing a tetrasaccharide comprising a 3-substituted glucose, a 6-substituted galactose, a 2,3-substituted glucose and nonreducing terminal galactose as a repeating unit, an extracellular polysaccharide produced by the lactobacillus, new Lactobacillus helveticus TDS030903 strain expectable to have immunomodulating action, and a food, an immunomodulating agent and a physical property improving agent containing the lactobacillus or polysaccharide are provided. PCOPYRIGHT: (C)2009,JPO&INPIT
机译:<要解决的问题:提供一种乳酸菌菌株,期望通过对人和动物口服给药具有免疫调节作用,并提供细胞外多糖。解决方案:提供了一种新的发酵乳杆菌TDS030603菌株,该菌株产生由主要成分组成的多糖,该主要成分包含四糖,该四糖包含3-取代的葡萄糖,6-取代的半乳糖,2,3-取代的葡萄糖和非还原性末端葡萄糖。重复单元和包含四糖的次要成分,所述四糖包含3-取代的葡萄糖,6-取代的半乳糖,2,3-取代的葡萄糖和非还原性末端半乳糖作为重复单元,由乳酸杆菌,新乳酸杆菌产生的细胞外多糖提供了预期具有免疫调节作用的TDS030903菌株,并提供了含有乳杆菌或多糖的食品,免疫调节剂和物理性质改善剂。

版权:(C)2009,日本特许厅&INPIT

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号